Author Archives: ScienceSpeaks

As an #Ebola outbreak raises unmet challenges, we’re reading how politics drives public health

Categories: What we’re readingWhile the World Health Organization’s announcement of an Ebola outbreak in the Democratic Republic of Congo raised appropriate alarm, the recognition of and response to the disease following nine cases of illness with three deaths over the last several weeks represent some degree of progress. The outbreak is the eighth in the country that was […](Read more…)

Posted in Aid, Aid & Development, Ebola, Infectious Disease | Tagged | Comments closed

Understanding of DRC #ebola outbreak unfolds and highlights the continuing challenges

Categories: U.S. Policy and FundingPending regulatory, ethics approvals in-country, DRC government, WHO and MSF preparing to offer investigational vaccine to contacts, including healthworkers, frontline teams Suspected cases all found in single health zone, WHO regional office reports A month after the current outbreak of Ebola in the Democratic Republic of Congo is believed to have begun, knowledge of where, […](Read more…)

Posted in Aid, Aid & Development, Ebola, Infectious Disease | Tagged , , | Comments closed

Expanded global gag rule restricting services to women will affect about $8.8 billion in U.S….

Categories: Transition 2017With a new policy titled “Protecting Life in Global Health Assistance,” the United States will restrict its international support for a broad array of medical services and disease responses that include HIV prevention and treatment, maternal and child health interventions, malaria care and control, Zika monitoring, surveillance, diagnosis, and more, the Department of State announced […](Read more…)

Posted in Aid & Development, General Global Health, Infectious Disease, Malaria, Women & Children | Tagged , , , | Comments closed

U.S. global health leadership more critical to security, stability and prosperity than ever,…

Categories: U.S. Policy and FundingAs priorities shift under new administration, report makes case that foreign assistance in U.S. interests, but requires improved efficiencies, sustainability In a report written with an eye to a new administration’s views on the value of foreign aid, and released Monday, the National Academies of Science, Engineering and Medicine makes a case that U.S. global […](Read more…)

Posted in Aid & Development, Funding, Global Health Corps, Infectious Disease | Tagged , | Comments closed

Biomedical research benefits bring House members, NIH leaders together

Categories: Research and DevelopmentIn the face of a proposal by the Trump administration to cut funding for the National Institutes of Health by nearly a quarter with an $8 billion drop, House members hold a hearing that covers “from AIDS to Zika,” the “Cancer Moonshot,” the quest for a universal flu vaccine, how researchers working in their own […](Read more…)

Posted in Aid & Development, General Global Health, Infectious Disease, Noncommunicable Disease | Tagged , , , , | Comments closed

We’re reading about USAID nominee Mark Green: Former Tanzania ambassador, Congressman,…

Categories: What We’re Reading About the 2017 TransitionWith an “America First” budget outline proposing massive cuts to foreign aid, global health and international medical research collaborations on the table, the Trump administration’s pick for the next head of USAID faces a landscape strewn with unpredictable challenges. With overseas exposure that began with a volunteer stint in Kenya, a term on the House […](Read more…)

Posted in Aid & Development, General Global Health, Infectious Disease | Tagged , | Comments closed

GeneXpert technology “a gold standard” to monitor Ebola risks among survivors

Categories: U.S. Policy and FundingThe Ebola epidemic in West Africa was waning in March 2015, when a new patient highlighted the danger that virus lingering in the semen of men who had recovered from the illness could continue to be transmitted months after the crisis had been declared over. The case of the patient, whose only exposure had been […](Read more…)

Posted in Aid & Development, Ebola, General Global Health, Infectious Disease | Tagged , , | Comments closed

Where harm reduction policies went up, hepatitis C incidence went down, study finds

Categories: U.S. Policy and FundingIn a study tracking numbers of new infections of hepatitis C and rates of sharing syringes among people injecting drugs over two and a half decades, differences in infection trends emerged across cities in North America, Australia and the Netherlands, researchers report in a recent Clinical Infectious Diseases. While rates of new infections remained high […](Read more…)

Posted in Aid & Development, General Global Health, Infectious Disease | Tagged , , | Comments closed

GeneXpert technology “a gold standard” to monitor Ebola risks among survivors

Categories: U.S. Policy and FundingThe Ebola epidemic in West Africa was waning in March 2015, when a new patient highlighted the danger that virus lingering in the semen of men who had recovered from the illness could continue to be transmitted months after the crisis had been declared over. The case of the patient, whose only exposure had been […](Read more…)

Posted in Ebola, General Global Health, Infectious Disease, Technology | Tagged , , | Comments closed

Study projects drug-resistant tuberculosis transmissions to climb in four countries

Categories: TBUsing data on outcomes and impacts of tuberculosis across four countries with some of the highest rates of the disease, researchers from the U.S. Centers for Disease Control and Prevention have found indications that person-to-person transmission will drive rising rates of TB that does not respond to treatments of first and second resort over the […](Read more…)

Posted in Infectious Disease, Tuberculosis | Tagged , | Comments closed

Funding for global health programs holds steady while biomedical research enjoys funding boost…

Categories: Budget, U.S. Policy and FundingYesterday, seven months into the fiscal year, the House of Representatives passed a fiscal year 2017 bill to fund government programs through September, and rejected the Trump Administration’s recommended cuts to global health funding. The Senate is expected to pass the massive spending measure by the end of the week and the President has indicated […](Read more…)

Posted in Aid & Development, General Global Health, Infectious Disease | Tagged , , | Comments closed

Stockouts among obstacles to TB/HIV treatment monitoring, training evaluation finds

Categories: HIV/AIDSTraining may have supported care outcome improvements In South Africa, where in 2014 an estimated 6,8 million people were living with HIV, and where an estimated 450,000 people became sick with tuberculosis that year, healthcare providers equipped to meet their needs are stretched thin, and training to help nurses manage patients who are infected with […](Read more…)

Posted in Aid & Development, General Global Health, Infectious Disease, Tuberculosis | Tagged , | Comments closed

Hepatitis preventable, treatable, beatable, but its toll is increasing, WHO report shows

Categories: U.S. Policy and FundingIn a report documenting multiple missed opportunities to detect, treat, cure, and prevent transmission of hepatitis B and C viruses, the World Health Organization recently released its first global estimates of the impact of the infections, showing their toll in 2015 exceeded deaths caused by HIV, and was comparable to the number of deaths caused […](Read more…)

Posted in General Global Health, Infectious Disease | Tagged , | Comments closed

We’re reading about India’s new HIV law as a measure of progress and missed opportunity

Categories: What we’re readingWith funding for HIV responses under threat at home and abroad, a look at the rights that are both protected and unaddressed under India’s new HIV law offers a chance to size up some of the greatest challenges to ending the public health threat of the virus more than three and a half decades into […](Read more…)

Posted in Aid, Aid & Development, General Global Health, HIV/AIDS, Infectious Disease, Policy & Systems, Politics | Tagged , | Comments closed